Pharma shares were trading higher on Sunday after Finance Minister Nirmala Sitharaman in her Budget speech said the government would unveil as a Bio Pharma Shakti scheme with an outlay of Rs 10,000 ...

Company to meet with prospective partners as it accelerates toward IND submission for Telomir-1, with plans to begin human dosing in the first half of 2026 MIAMI, FL / ACCESS Newswire / June 2, 2025 / ...

As Samsung Biologics’ contract manufacturing business continues to fire on all cylinders, the CDMO has earned a unique ...

Union Finance Minister Nirmala Sitharaman made one of the most significant announcements of Budget 2026 by unveiling ‘Biopharma Shakti', a flagship initiative with an outlay of ₹10,000 crore over the ...

Finance Minister Nirmala Sitharaman on Sunday announced a Rs 10,000 crore outlay for the Bio Pharma Shakti scheme for ...

Finance Minister Nirmala Sitharaman highlighted the growing burden of diabetes, obesity and cancer in India in her 9th Budget ...

As part of the plan, Finance Minister Nirmala Sitharaman proposed 'Bio Pharma Shakti', a dedicated outlay of Rs 5,000 crore over five years, to accelerate capacity building and support advanced ...

The MarketWatch News Department was not involved in the creation of this content. HANGZHOU, China and SHANGHAI and BOSTON, Dec. 10, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter ...

DORADO, PR / ACCESS Newswire / January 29, 2026 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and technology ...

Processa Pharmaceuticals, Inc. announced its participation in the 2025 BIO International Convention from June 16-19 in Boston, where key executives, including CEO Georg Ng and President of R&D Dr.

Patna, Feb 1 (PTI) Bihar Deputy Chief Minister Samrat Choudhary on Sunday hailed the Union Budget (2026-27) presented by ...

The Union Budget 2026–27 proposed a Rs 10,000 crore Bio Pharma Shakti scheme to boost biologics and biosimilars, alongside ...